| Guidelines for the use and interpretation of assays for monitoring autophagy DJ Klinonsky Autophagy, 2016 | 10678* | 2016 |
| Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson disease V Jackson-Lewis, M Vila, K Tieu, P Teismann, C Vadseth, DK Choi, ... Journal of Neuroscience 22 (5), 1763-1771, 2002 | 1462 | 2002 |
| Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease GT Liberatore, V Jackson-Lewis, S Vukosavic, AS Mandir, M Vila, ... Nature medicine 5 (12), 1403-1409, 1999 | 1247 | 1999 |
| Pathogenic lysosomal depletion in Parkinson's disease B Dehay, J Bové, N Rodríguez-Muela, C Perier, A Recasens, P Boya, ... Journal of Neuroscience 30 (37), 12535-12544, 2010 | 922 | 2010 |
| Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration P Teismann, K Tieu, DK Choi, DC Wu, A Naini, S Hunot, M Vila, ... Proceedings of the National Academy of Sciences 100 (9), 5473-5478, 2003 | 764 | 2003 |
| NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson's disease DC Wu, P Teismann, K Tieu, M Vila, V Jackson-Lewis, H Ischiropoulos, ... Proceedings of the National Academy of Sciences 100 (10), 6145-6150, 2003 | 742 | 2003 |
| Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP W Dauer, N Kholodilov, M Vila, AC Trillat, R Goodchild, KE Larsen, ... Proceedings of the National Academy of Sciences 99 (22), 14524-14529, 2002 | 722 | 2002 |
| Targeting programmed cell death in neurodegenerative diseases M Vila, S Przedborski Nature Reviews Neuroscience 4 (5), 365-375, 2003 | 714 | 2003 |
| Lewy body extracts from Parkinson disease brains trigger α‐synuclein pathology and neurodegeneration in mice and monkeys A Recasens, B Dehay, J Bové, I Carballo‐Carbajal, S Dovero, ... Annals of neurology 75 (3), 351-362, 2014 | 690 | 2014 |
| Series Introduction: Neurodegeneration: What is it and where are we? S Przedborski, M Vila, V Jackson-Lewis The Journal of clinical investigation 111 (1), 3-10, 2003 | 662 | 2003 |
| Disease‐specific phenotypes in dopamine neurons from human iPS‐based models of genetic and sporadic Parkinson's disease A Sánchez‐Danés, Y Richaud‐Patin, I Carballo‐Carbajal, ... EMBO molecular medicine 4 (5), 380-395, 2012 | 628 | 2012 |
| Fighting neurodegeneration with rapamycin: mechanistic insights J Bové, M Martínez-Vicente, M Vila Nature Reviews Neuroscience 12 (8), 437-452, 2011 | 577 | 2011 |
| D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease K Tieu, C Perier, C Caspersen, P Teismann, DC Wu, SD Yan, A Naini, ... The Journal of clinical investigation 112 (6), 892-901, 2003 | 558 | 2003 |
| Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations B Dehay, M Bourdenx, P Gorry, S Przedborski, M Vila, S Hunot, ... The Lancet Neurology 14 (8), 855-866, 2015 | 523 | 2015 |
| JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease S Hunot, M Vila, P Teismann, RJ Davis, EC Hirsch, S Przedborski, ... Proceedings of the National Academy of Sciences 101 (2), 665-670, 2004 | 506 | 2004 |
| α‐Synuclein Up‐Regulation in Substantia Nigra Dopaminergic Neurons Following Administration of the Parkinsonian Toxin MPTP M Vila, S Vukosavic, V Jackson‐Lewis, M Neystat, M Jakowec, ... Journal of neurochemistry 74 (2), 721-729, 2000 | 485 | 2000 |
| Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson's disease M Vila, V Jackson-Lewis, S Vukosavic, R Djaldetti, G Liberatore, D Offen, ... Proceedings of the National Academy of Sciences 98 (5), 2837-2842, 2001 | 448 | 2001 |
| The role of glial cells in Parkinson's disease M Vila, V Jackson-Lewis, C Guégan, P Teismann, DK Choi, K Tieu, ... Current opinion in neurology 14 (4), 483-489, 2001 | 417 | 2001 |
| Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration B Dehay, A Ramirez, M Martinez-Vicente, C Perier, MH Canron, ... Proceedings of the National Academy of Sciences 109 (24), 9611-9616, 2012 | 378 | 2012 |
| Genetic clues to the pathogenesis of Parkinson's disease M Vila, S Przedborski Nature medicine 10 (7), S58-S62, 2004 | 378 | 2004 |
